A detailed history of Altus Wealth Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Altus Wealth Group LLC holds 614 shares of LLY stock, worth $556,719. This represents 0.24% of its overall portfolio holdings.

Number of Shares
614
Previous 597 2.85%
Holding current value
$556,719
Previous $348,000 37.07%
% of portfolio
0.24%
Previous 0.19%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $10,067 - $13,468
17 Added 2.85%
614 $477,000
Q4 2023

Jan 29, 2024

BUY
$525.19 - $619.13 $2,100 - $2,476
4 Added 0.67%
597 $348,000
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $4,347 - $5,993
-10 Reduced 1.66%
593 $318,000
Q4 2022

Jan 18, 2023

BUY
$321.55 - $374.67 $193,894 - $225,926
603 New
603 $0
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $42,887 - $55,519
-261 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $34,050 - $45,056
261 New
261 $44,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $862B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Altus Wealth Group LLC Portfolio

Follow Altus Wealth Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altus Wealth Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altus Wealth Group LLC with notifications on news.